Oscar Health Inc (OSCR) PT Raised to $33 at Baird

September 17, 2026 7:11 AM

Baird analyst Michael Ha raised the price target on Oscar Health Inc (NYSE: OSCR) to $33.00 (from $27.00) while maintaining a Neutral rating.

No results found